Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

A surprising discovery could help aging muscles repair themselves | ScienceDaily (opens in a new tab)

sciencedaily.com · 2026-11-04

Short answerEvidenceSource

Short answer

Mixed

Mixed.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

  • 2 supported
  • 2 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

Every claim we could check holds up. Two of four claims match the study. This overall rating is based only on the claims we could check. Two claims the study doesn't address.

  • 2 supported
  • 2 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

4 claims in this story

Showing all 4 claimsChoose a verdict to focus the list.

Claim 1 of 4Not coveredThe team, led by Professor Ryuichi Tatsumi at Kyushu University, says the findings were published in Scientific Reports and suggest a possible new approach to aging-related muscle repair problems.View evidenceHide evidence

Why this verdict

The paper profile supports a hedged implication that LASSS-mediated protection/enhancement of HGF could be relevant to aging-related muscle repair biology. However, the supplied abstract-level profile does not verify the claimed lead investigator, Kyushu University affiliation, or publication venue in Scientific Reports, so the full claim is not verifiable at this depth.

1

Study evidence

LASSS-treated HGF (LASSS:HGF 1:8000, followed by ultrafiltration) showed increased binding affinity to the c‑met receptor compared with the original non-nitrated HGF.>2-fold

“When evaluated after exposure to LASSS at a 1:8000 molar ratio to HGF and subsequent ultra-filtration to wash-out un-reacted free LASSS, c-met binding affinity increased more than two-fold over the original non-nitrated HGF.”
2

Study evidence

Pre-treatment of HGF with LASSS confers resistance to peroxynitrite-induced tyrosine nitration, with a greater protective effect at Y198 than at Y250.

“The same LASSS treatment also conferred nitration resistance with a greater effect for Y198 than Y250, indicating a novel mechanism independent of an anti-oxidative function of LASSS.”
Claim 2 of 4Not coveredIn mice subjected to tail suspension, pretreatment with LASSS significantly reduced HGF nitration, but the study did not demonstrate restored muscle mass or improved physical strength.View evidenceHide evidence

Why this verdict

The abstract-level profile supports the core direction that LASSS pre-administration prevented disuse-induced HGF nitration in a mouse tail-suspension model and that no functional muscle outcome is described. But the story’s wording that nitration was “significantly” reduced is not verifiable from the abstract-level profile, which lacks p-values, sample sizes, confidence intervals, and statistical details.

1

Study evidence

Pre-administration of LASSS prevented disuse-induced HGF nitration in a mouse tail-suspension muscle atrophy model; GSSSG did not.

“Importantly, pre-administration of LASSS to mice prevented the disuse-induced HGF nitration observed in a tail-suspension model for muscle atrophy, while GSSSG did not.”
Claim 3 of 4SupportedResearchers identified a compound that can transform the muscle-repair protein HGF into a more powerful version, dubbed "Super HGF," by more than doubling its ability to bind to the c-met receptor while protecting it from age-related chemical damage.View evidenceHide evidence

As statedmore than twice the binding affinity

Why this verdict

The abstract-level profile supports that LASSS interacts with HGF to produce an enhanced HGF state with >2-fold increased c-met binding affinity and resistance to peroxynitrite-driven tyrosine nitration. The in vivo mouse result also supports protection from disuse-induced HGF nitration. The headline-style wording such as “Super HGF” and “more powerful” is promotional, but the claim ties that wording to the supported biochemical endpoints rather than claiming demonstrated muscle repair.

1

Study evidence

LASSS-treated HGF (LASSS:HGF 1:8000, followed by ultrafiltration) showed increased binding affinity to the c‑met receptor compared with the original non-nitrated HGF.>2-fold

“When evaluated after exposure to LASSS at a 1:8000 molar ratio to HGF and subsequent ultra-filtration to wash-out un-reacted free LASSS, c-met binding affinity increased more than two-fold over the original non-nitrated HGF.”
2

Study evidence

Pre-treatment of HGF with LASSS confers resistance to peroxynitrite-induced tyrosine nitration, with a greater protective effect at Y198 than at Y250.

“The same LASSS treatment also conferred nitration resistance with a greater effect for Y198 than Y250, indicating a novel mechanism independent of an anti-oxidative function of LASSS.”
Claim 4 of 4SupportedIn laboratory experiments, LASSS reduced nitration at two vulnerable HGF sites and, at a higher molar ratio, increased HGF's binding affinity for c-met by more than twofold; the effect was specific to LASSS and not seen with glutathione trisulfide (GSSSG).View evidenceHide evidence

As statedmore than twice the binding affinity

Why this verdict

The abstract-level evidence supports the in vitro claim: LASSS-treated HGF showed >2-fold higher c-met binding affinity after treatment and ultrafiltration, and LASSS conferred resistance to peroxynitrite-driven nitration at Y198 and Y250, with controls GSSSG and lipoic acid not reproducing the binding or nitration-resistance effects. The profile specifically identifies the tested high LASSS:HGF ratio as 1:8000 for the binding assay.

1

Study evidence

LASSS-treated HGF (LASSS:HGF 1:8000, followed by ultrafiltration) showed increased binding affinity to the c‑met receptor compared with the original non-nitrated HGF.>2-fold

“When evaluated after exposure to LASSS at a 1:8000 molar ratio to HGF and subsequent ultra-filtration to wash-out un-reacted free LASSS, c-met binding affinity increased more than two-fold over the original non-nitrated HGF.”
2

Study evidence

Pre-treatment of HGF with LASSS confers resistance to peroxynitrite-induced tyrosine nitration, with a greater protective effect at Y198 than at Y250.

“The same LASSS treatment also conferred nitration resistance with a greater effect for Y198 than Y250, indicating a novel mechanism independent of an anti-oxidative function of LASSS.”
Then look for missing context

Context layer

What the story carried across

Nothing material from the study was dropped.

6 things the story did carry across
  • LASSS-treated HGF showed more than twofold increased c-met receptor-binding affinity in vitro after exposure at a 1:8000 molar ratio and ultrafiltration washout.
  • The enhanced binding effect was specific to LASSS among tested related/antioxidant controls; GSSSG and lipoic acid did not enhance c-met binding.
  • LASSS conferred resistance to peroxynitrite-driven HGF tyrosine nitration at Y198 and Y250, with greater protection at Y198 than Y250.
  • In vivo mouse tail-suspension evidence showed LASSS pre-administration prevented disuse-induced HGF nitration, while GSSSG did not.
  • The paper profile does not show that LASSS restored muscle mass, improved strength, or demonstrated improved muscle regeneration in vivo.
  • Physiological generalizability remains limited: the in vivo evidence is from a single mouse tail-suspension disuse model, and effectiveness/safety in aging animals or broader contexts is not established in the abstract-level profile.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

3

Evidence read

study summary

Lead result

in vitro

1Lead resultin vitroLASSS interacts with HGF under physiological conditions to produce an ‘enhanced HGF’ state with increased c-met receptor-binding affinity and resistance to peroxynitrite-driven tyrosine nitration dysfunction, an effect not explained by generic antioxidant activity (contrasted with GSSSG and lipoic acid controls).in vitro biochemical incubation and receptor-binding assayExpand

In plain English

In vitro exposure of HGF to lipoic acid trisulfide (LASSS) at a 1:8000 molar ratio followed by ultrafiltration to remove unreacted compound produced an HGF state with >2-fold increased c‑met binding affinity compared with the original non-nitrated HGF; the effect was not reproduced by glutathione trisulfide (GSSSG) or lipoic acid. The same LASSS treatment also conferred resistance to peroxynitrite-driven tyrosine nitration, with a larger effect at Y198 than Y250.

Key findings

  • LASSS-treated HGF (LASSS:HGF 1:8000, followed by ultrafiltration) showed increased binding affinity to the c‑met receptor compared with the original non-nitrated HGF.>2-fold
  • The LASSS treatment conferred resistance to peroxynitrite-driven tyrosine nitration, with greater protection at Y198 than Y250.
“When evaluated after exposure to LASSS at a 1:8000 molar ratio to HGF and subsequent ultra-filtration to wash-out un-reacted free LASSS, c-met binding affinity increased more than two-fold over the original non-nitrated HGF.”
What this piece can’t prove

4 further details could not be confirmed from the summary.

2in vitroLASSS interacts with HGF under physiological conditions to produce an ‘enhanced HGF’ state with increased c-met receptor-binding affinity and resistance to peroxynitrite-driven tyrosine nitration dysfunction, an effect not explained by generic antioxidant activity (contrasted with GSSSG and lipoic acid controls).in vitro nitration-resistance assayExpand

In plain English

In an in vitro peroxynitrite (ONOO−) challenge assay, pre-treatment of HGF with lipoic acid trisulfide (LASSS) conferred resistance to tyrosine nitration, with a greater protective effect at residue Y198 than at Y250. The nitration-resistance effect was not observed with control treatments using glutathione trisulfide (GSSSG) or lipoic acid, suggesting the effect is not explained solely by generic antioxidant activity.

Key findings

  • Pre-treatment of HGF with LASSS confers resistance to peroxynitrite-induced tyrosine nitration, with a greater protective effect at Y198 than at Y250.
  • Control compounds (GSSSG and lipoic acid) did not confer nitration resistance, indicating the observed LASSS effect is unlikely to be a generic antioxidant action.
“The same LASSS treatment also conferred nitration resistance with a greater effect for Y198 than Y250, indicating a novel mechanism independent of an anti-oxidative function of LASSS.”
What this piece can’t prove
  • Abstract lacks methodological detail for the nitration assay (specific detection techniques, replication, statistical analysis).

3 further details could not be confirmed from the summary.

3in vivo animalPre-administration of LASSS in vivo prevents disuse-induced HGF nitration in a mouse tail-suspension muscle atrophy model (while GSSSG does not), supporting physiological relevance of LASSS-mediated protection of HGF from nitration.in vivo animal (mouse tail-suspension, pre-administration of compound)Expand

In plain English

In a mouse tail-suspension disuse model of muscle atrophy, pre-administration of lipoic acid trisulfide (LASSS) prevented the disuse-induced nitration of hepatocyte growth factor (HGF); glutathione trisulfide (GSSSG) did not prevent HGF nitration (abstract-reported result).

Key findings

  • Pre-administration of LASSS prevented disuse-induced HGF nitration in a mouse tail-suspension muscle atrophy model; GSSSG did not.
“Importantly, pre-administration of LASSS to mice prevented the disuse-induced HGF nitration observed in a tail-suspension model for muscle atrophy, while GSSSG did not.”
What this piece can’t prove

3 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 37 candidate papers

Candidate

2.112P Multi-layered nitration of HGF/c-met axis impairs muscle regeneration during aging

Neuromuscular Disorders · 2026 · Crossref

Source (opens in a new tab)
Candidate

Author Correction: Inference limits in partially observable Ethereum blockchains

Scientific Reports · 2026 · Crossref

Source (opens in a new tab)
Candidate

Author Correction: Age differences in alcohol and music consumption among Japanese nonproblem drinkers

Scientific Reports · 2026 · Crossref

Source (opens in a new tab)

And 31 more candidates considered.